What are the potential risks and benefits of administering low molecular weight heparin for thromboprophylaxis in cancer patients during hospitalization?
Year: 2026
Type: article
Abstract: Low molecular weight heparin is effective for thromboprophylaxis in hospitalized cancer patients, significantly reducing VTE incidence. It has a favorable risk profile, though monitoring for bleeding and HIT is essential.
Author: Tripdatabase
Language: English
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7235796818
